Literature DB >> 10661362

Non-small cell lung tumors repopulate rapidly during radiation therapy.

J F Fowler, R Chappell.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 10661362     DOI: 10.1016/s0360-3016(99)00364-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  35 in total

Review 1.  21 years of biologically effective dose.

Authors:  J F Fowler
Journal:  Br J Radiol       Date:  2010-07       Impact factor: 3.039

Review 2.  Novel approaches of chemoradiotherapy in unresectable stage IIIA and stage IIIB non-small cell lung cancer.

Authors:  Thomas E Stinchcombe; Jeffrey A Bogart
Journal:  Oncologist       Date:  2012-04-24

3.  Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays.

Authors:  M Maciá I Garau; J Solé Monné; M J Cambra Serés; C Monfà Binefa; M Peraire Llopis
Journal:  Clin Transl Oncol       Date:  2009-05       Impact factor: 3.405

Review 4.  Linear quadratic and tumour control probability modelling in external beam radiotherapy.

Authors:  S F C O'Rourke; H McAneney; T Hillen
Journal:  J Math Biol       Date:  2008-09-30       Impact factor: 2.259

5.  An individualized radiation dose escalation trial in non-small cell lung cancer based on FDG-PET imaging.

Authors:  Marie Wanet; Antoine Delor; François-Xavier Hanin; Benoît Ghaye; Aline Van Maanen; Vincent Remouchamps; Christian Clermont; Samuel Goossens; John Aldo Lee; Guillaume Janssens; Anne Bol; Xavier Geets
Journal:  Strahlenther Onkol       Date:  2017-07-21       Impact factor: 3.621

Review 6.  Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models.

Authors:  Feng Liu; An Tai; Percy Lee; Tithi Biswas; George X Ding; Isaam El Naqa; Jimm Grimm; Andrew Jackson; Feng-Ming Spring Kong; Tamara LaCouture; Billy Loo; Moyed Miften; Timothy Solberg; X Allen Li
Journal:  Radiother Oncol       Date:  2016-11-18       Impact factor: 6.280

7.  Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group.

Authors:  Mitchell Machtay; Kyounghwa Bae; Benjamin Movsas; Rebecca Paulus; Elizabeth M Gore; Ritsuko Komaki; Kathy Albain; William T Sause; Walter J Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-25       Impact factor: 7.038

8.  Outcomes of accelerated hypofractionated radiotherapy in stage i non-small-cell lung cancer.

Authors:  T Yung; M E Giuliani; L W Le; A Sun; B C J Cho; A Bezjak; A Brade; A J Hope
Journal:  Curr Oncol       Date:  2012-08       Impact factor: 3.677

9.  Triaging early-stage lung cancer patients into non-surgical pathways: who, when, and what?

Authors:  Rameses Sroufe; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2015-08

10.  Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904.

Authors:  Jeffrey A Bogart; Lydia Hodgson; Stephen L Seagren; A William Blackstock; Xiaofei Wang; Robert Lenox; Andrew T Turrisi; John Reilly; Ajeet Gajra; Everett E Vokes; Mark R Green
Journal:  J Clin Oncol       Date:  2009-11-23       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.